Johnson & Johnson has launched the TECNIS Odyssey intraocular lens (IOL), part of its presbyopia-correcting intraocular lenses (PC-IOL) portfolio, across Europe, the Middle East, and Canada.
The next-generation lens promises enhanced vision quality for cataract patients, offering precise vision across all distances and lighting conditions.
TECNIS Odyssey IOL is designed based on the company’s TECNIS platform to provide crisp, clear vision, allowing patients to see clearly at all distances.
Also, the intraocular lens enables ophthalmologists to address presbyopia during cataract surgery by providing a full visual range.
Johnson & Johnson Vision chairman Peter Menziuso said: “TECNIS Odyssey IOL is the fastest growing PC-IOL in the United States, and we are excited to be making it available to more patients around the world.
“It addresses a significant unmet need for cataract patients seeking greater spectacle independence.
“Now, together with TECNIS PureSee, TECNIS Odyssey IOL elevates the strength and depth of our global IOL portfolio, meeting the diverse needs of today’s ageing population.”
TECNIS Odyssey IOL features a unique freeform diffractive surface that eliminates gaps between near, intermediate, and far distances, ensuring continuous vision.
It offers a high level of patient satisfaction, with 94% of patients reporting satisfaction with their overall vision without glasses.
The lens is engineered to minimise night vision disturbances such as halos and glare, providing better image quality for a comfortable lighting adaptability during night-time.
According to the company, 92% of patients expressed satisfaction with their ability to navigate steps and read street signs at night.
The TECNIS platform, which includes the TECNIS Odyssey IOL and TECNIS PureSee IOL, offers a variety of options tailored to different visual needs and lifestyles.
The TECNIS Odyssey IOL is also available in the US, Puerto Rico, and Japan, while the TECNIS PureSee IOL is available across the Asia-Pacific region and Latin America.
Brest University Hospital Ophthalmology Department head Beatrice Cochener-Lamard said: “From my early experience, what sets the TECNIS Odyssey IOL apart, is its ability to deliver consistent visual outcomes across a wide range of patients, due to its advanced design with higher tolerance to residual refractive error.”
